Advancement of AbbVie Inc. and OSE Immunotherapeutics strategic partnership to develop ABBV-230: in April 2024, the Hart-Scott-Rodino waiting period expired enabling teams to commence work around the ...

A third of women infrequently, if ever, orgasm during sex. It’s a major inequity, one that Osé founder Lora Haddock was trying to solve when she came up against another: sexism in tech.